Table of Contents
Overview
SMARCA4 is a member of the SWI/SNF family of proteins. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which can allow expression of genes repressed by chromatin. Overall, components of SWI/SNF have been identified as an emerging theme in germinal centre-derived B-cell lymphomas.1
Experimental Evidence
Driver mutations affecting this gene in DLBCL/FL/BL have been experimentally demonstrated to cause a reduction or loss of function (LOF).2
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 1 | High-confidence BL gene | |
| 1 | High-confidence DLBCL gene | |
| 1 | High-confidence FL gene | |
| 1 | High-confidence MCL gene | |
| 2 | Role of SMARCA4 mutations in PMBL requires confirmation |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
DLBCL
| Entity | Collection | N | mutated | Incidence | 95% CI |
|---|---|---|---|---|---|
| DLBCL | GAMBL without Reddy | 1,089 | 27 | 0.0248 | [0.0156,0.034] |
| DLBCL | GAMBL with Reddy | 2,088 | 60 | 0.0287 | [0.0216,0.0359] |
| DLBCL | BC | 231 | 5 | 0.0216 | [0.0029,0.0404] |
| DLBCL | Dana-Farber | 303 | 5 | 0.0165 | [0.0022,0.0308] |
| DLBCL | NCI | 470 | 14 | 0.0298 | [0.0144,0.0452] |
| DLBCL | Reddy | 999 | 33 | 0.0330 | [0.022,0.0441] |
| DLBCL | DLBCL_ICGC | 85 | 3 | 0.0353 | [0,0.0745] |
FL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| FL | GAMBL without Crouch | 642 | 25 | 0.0389 | [0.024,0.0539] |
| FL | GAMBL with Crouch | 1,189 | 64 | 0.0538 | [0.041,0.0667] |
| FL | BC | 379 | 13 | 0.0343 | [0.016,0.0526] |
| FL | Kalmbach | 164 | 9 | 0.0549 | [0.02,0.0897] |
| FL | Crouch | 547 | 39 | 0.0713 | [0.0497,0.0929] |
| FL | FL_ICGC | 99 | 3 | 0.0303 | [0,0.0641] |
BL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| BL | GAMBL without Panea | 309 | 76 | 0.2245 | [0.1791,0.2698] |
| BL | GAMBL without ICGC/Zhou | 320 | 58 | 0.1812 | [0.139,0.2234] |
| BL | GAMBL with Panea | 410 | 95 | 0.2150 | [0.176,0.2539] |
| BL | BLGSP | 219 | 39 | 0.1781 | [0.1274,0.2288] |
| BL | Zhou/ICGC | 90 | 37 | 0.4111 | [0.3095,0.5128] |
| BL | Panea | 101 | 19 | 0.1881 | [0.1119,0.2643] |
MCL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| MCL | GAMBL | 160 | 10 | 0.0620 | [0.0247,0.0994] |
| MCL | BC_MCL | 103 | 6 | 0.0583 | [0.013,0.1035] |
| MCL | Barcelona | 57 | 4 | 0.0702 | [0.0039,0.1365] |
Mutation pattern and selective pressure estimates
| Entity | Missense dN/dS | Nonsense dN/dS | Q value |
|---|---|---|---|
| BL | 16.4107 | 5.8661 | 0.0000 |
| FL | 4.9909 | 0.0000 | 0.2962 |
| DLBCL | 1.5958 | 2.1520 | 0.4033 |
Visualizations
Protein
View coding variants in ProteinPaint hg19 or hg38
Genome
View all variants in GenomePaint hg19 or hg38
Expression
History
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2012-11-11 : Richter : BL
2013-01-01 : Zhang : DLBCL
2017-01-26 : Krysiak : FL
2020-09-17 : Nadeu : MCL
References
1.
Lunning MA, Green MR. Mutation of chromatin
modifiers; an emerging hallmark of germinal center B-cell lymphomas. Blood Cancer J. 2015 Oct
16;5(10):e361. PMCID: PMC4635197
2.
Fernando TM, Piskol R, Bainer R, Sokol ES,
Trabucco SE, Zhang Q, Trinh H, Maund S, Kschonsak M, Chaudhuri S,
Modrusan Z, Januario T, Yauch RL. Functional characterization of
SMARCA4 variants identified by targeted exome-sequencing of
131,668 cancer patients. Nat Commun. 2020 Nov 3;11(1):5551. PMCID: PMC7609548
3.
Deng
Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, Chin C, Zhang W, Dinh T,
Hussein U, Li X, Rojas E, Liu W, Reville PK, Kizhakeyil A, Barisic D,
Parsons S, Wilson A, Henderson J, Scull B, Gurumurthy C, Vega F,
Chadburn A, Cuglievan B, El-Mallawany NK, Allen C, Mason C, Melnick A,
Green MR. SMARCA4 is a haploinsufficient B
cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate
decisions. Cancer Cell. 2024 Apr 8;42(4):605–622.e11. PMCID: PMC11003852
4.
Krysiak K, Gomez F, White BS, Matlock M, Miller
CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR,
Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA.
Recurrent somatic mutations affecting B-cell
receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan
26;129(4):473–483. PMCID: PMC5270390
5.
Lohr
JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C,
Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A,
Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N,
Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A,
Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A,
Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES,
Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Discovery and
prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by
whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar
6;109(10):3879–3884. PMCID: PMC3309757
6.
Nadeu F, Martín-García D, Clot G, Díaz-Navarro
A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R,
Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggrós M,
Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A,
Ribera‐Cortada I, Siebert R, Colomer D, Torrents D, Giné E,
López-Guillermo A, Küppers R, Martín-Subero J, Puente X, Beà S, Campo E.
Genomic and
epigenomic insights into the origin, pathogenesis and clinical behavior
of mantle cell lymphoma subtypes. Blood. 2020;
7.
Richter J, Schlesner M, Hoffmann S, Kreuz M,
Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH,
Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages
S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO,
Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S,
Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik
R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P,
MacLeod RAF, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF,
Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P,
Rosenwald A, Brors B, Siebert R, ICGC MMML-Seq Project. Recurrent mutation of the
ID3 gene in Burkitt lymphoma identified by
integrated genome, exome and transcriptome sequencing. Nat Genet.
2012 Dec;44(12):1316–1320.


